DE20306600U1 - Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier - Google Patents
Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrierInfo
- Publication number
- DE20306600U1 DE20306600U1 DE20306600U DE20306600U DE20306600U1 DE 20306600 U1 DE20306600 U1 DE 20306600U1 DE 20306600 U DE20306600 U DE 20306600U DE 20306600 U DE20306600 U DE 20306600U DE 20306600 U1 DE20306600 U1 DE 20306600U1
- Authority
- DE
- Germany
- Prior art keywords
- tincture
- milk fat
- ointment base
- skin
- wound care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000021243 milk fat Nutrition 0.000 title claims abstract description 10
- 239000003883 ointment base Substances 0.000 title claims abstract description 10
- 229940098465 tincture Drugs 0.000 title claims abstract description 10
- 241000219000 Populus Species 0.000 title claims abstract 3
- 239000011347 resin Substances 0.000 title claims abstract 3
- 229920005989 resin Polymers 0.000 title claims abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 239000000126 substance Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 241000241413 Propolis Species 0.000 description 20
- 229940069949 propolis Drugs 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 239000002674 ointment Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000006071 cream Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 210000000003 hoof Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017564 Fusobacterium infections Diseases 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 206010028846 Necrobacillosis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Vera & Peter Karpfl - Reeserstr. 132 - 47546 Kaikar - Tel: 02824 - 804104Vera & Peter Karpfl - Reeserstr. 132 - 47546 Kaikar - Tel: 02824 - 804104
Gegenstand der vorliegenden Anmeldung ist die Verwendung von Propolis in seiner Benutzung als Creme, zur Wundheilung, bzw. Wundbehandlung, sprich, offener Wundbehandlung, ihrer Herstellung und die damit verbundenen sonstigen Anwendungsformen.The subject matter of the present application is the use of propolis in its use as a cream, for wound healing or wound treatment, i.e. open wound treatment, its production and the associated other forms of application.
Die topische Verwendung von Propolis unter der Prämisse eines Antiphlogistikums, sowie als Lokalanästhetikum in Bezug auf Schleimhäute und Epithelgewebe ist bereits bekannt. Hier soll nun Propolis, mit Melkfett oder anderen Trägersubstanzen als Salbengrundlage, zur lokalanästethischen, bakteriziden und granulationsfördernden Behandlung bei Verletzungen, Verbrennungen, Entzündungen der Cutis und Subcutis, Fistelbildungen, Nekrosen, Huf und Klauenerkrankungen, Mauke und Hufrehe, als auch bei Blutergüssen (Hämatomen) seine Verwendung finden. Ebenso die Anwendung zur Förderung des Granulationsgewebes bei kleinen bis großen Wunden, da Propolis in dieser Verbindung eine enorm hohe wundreinigende (bakterizide) und granulationsfördernde Eigenschaft besitzt, aber auch als Haut- und Hufpflegeprodukt.The topical use of propolis under the premise of an anti-inflammatory agent, as well as a local anesthetic for mucous membranes and epithelial tissue, is already known. Here, propolis, with milk fat or other carrier substances as an ointment base, is to be used for local anesthetic, bactericidal and granulation-promoting treatment for injuries, burns, inflammation of the cutis and subcutis, fistula formation, necrosis, hoof and claw diseases, mud fever and laminitis, as well as for bruises (hematomas). It can also be used to promote granulation tissue in small to large wounds, as propolis in this combination has extremely high wound-cleansing (bactericidal) and granulation-promoting properties, but also as a skin and hoof care product.
Herstellung der Propolis Salbe:Production of propolis ointment:
1.) 8-10 Gramm Propolis Tinktur auf 100 Gramm reines Melkfett, oder anderen1.) 8-10 grams of propolis tincture to 100 grams of pure milk fat, or other
Trägersubstanzen als Salbengrundlage (10%ige Propoliscreme) 2.) 15 Gramm Propolis Tinktur auf 100 Gramm reines Melkfett, oder anderenCarrier substances as ointment base (10% propolis cream) 2.) 15 grams of propolis tincture to 100 grams of pure milk fat, or other
Trägersubstanzen als Salbengrundlage (15%ige Propoliscreme) 3.) 8-10 Gramm Propolis Granulat nach der Herstellung der Tinktur als Restbestand nach Abseihen auf 100 Gramm reines Melkfett, oder anderen Trägersubstanzen alsCarrier substances as ointment base (15% propolis cream) 3.) 8-10 grams of propolis granules after the preparation of the tincture as a residue after straining to 100 grams of pure milk fat, or other carrier substances as
Salbenrundlage (10%ige Propoliscreme)
4.) 15 Gramm Propolis Granulat nach der Herstellung der Tinktur als Restbestand nach Abseihen auf 100 Gramm reines Melkfett, oder anderen Trägersubstanzen als Salbengrundlage ( 15%ige Propoliscreme )Ointment base (10% propolis cream)
4.) 15 grams of propolis granules after making the tincture as a residue after straining into 100 grams of pure milk fat, or other carrier substances as an ointment base (15% propolis cream)
Durch den Einsatz von Propolis Salbe in den oben bezeichneten Anwendungsgebieten, konnte durch mehrere Versuche festgestellt werden, dass es bei der Wunde, durch die Heilung von der Peripherie aus, unter Bildung eines intakten Granulationsgewebes, noch nicht einmal zu einer Narbenbildung kommt. Somit ist davon auszugehen, dass unter Verwendung und dem Einsatz der Propolis Salbe es zu einer Restitutio ad integrum kommt und zwar des kompletten Gewebeapparates.By using propolis ointment in the above-mentioned areas of application, several tests have shown that the wound heals from the periphery and forms intact granulation tissue, without even scarring. It can therefore be assumed that the use of propolis ointment leads to a restitutio ad integrum of the entire tissue system.
Auch wurde durch mehrere Versuche bestätigt, dass Propolis in seiner Anwendung der unter 1-4 beschriebenen Herstellungsverfahren, als Hautpflege- bzw. Huf-Klauenpflegeprodukt in Bezug auf die Anwendung bei Huf- und Klauentiere, diese unter weit aus weniger Problematiken in Bezug auf Nekrobazillosen noch Hufrehen, Hufspalten, Mauke etc., litten. Auch wurde in den verschiedenen Versuchen festgestellt, dass Propolis eine anästhetische Wirkung beinhaltet. Dies konnte wie folgt festgestellt werden:It has also been confirmed by several tests that when propolis is used in the manufacturing processes described under 1-4 as a skin care or hoof care product for hoofed animals, these animals suffer from far fewer problems with regard to necrobacillosis, laminitis, hoof cracks, mud fever, etc. It was also found in the various tests that propolis has an anesthetic effect. This was determined as follows:
Bei der Behandlung eines Pferdes mit großer Fleischwunde, wurde Propolis-Salbe in der Herstellungsweise wie unter 4 beschrieben in die Wunde und auf das umgebende Wundgebiet aufgetragen.When treating a horse with a large flesh wound, propolis ointment was applied to the wound and the surrounding wound area using the method described under 4.
Bei der Erstbehandlung zeugte das zu behandelnde Tier noch Schmerzsymptomatik, welche sich allerdings, bereits 5 Stunden später, bei der Zweitbehandlung nicht mehr äußerten.During the first treatment, the animal still showed pain symptoms, which, however, disappeared during the second treatment just 5 hours later.
Auch spätere Behandlungen ließ das Tier problemlos über sich ergehen.The animal also tolerated subsequent treatments without any problems.
Weiter wurde festgestellt, dass es bereits nach dem 2. Tag zu einer Proliferation kam und die Regeneration des Gewebes bereits eingesetzt hatte, eine entzündliche Exsudation bliebIt was further determined that proliferation had already occurred after the second day and tissue regeneration had already begun, but inflammatory exudation remained
vollständig aus.completely.
Die Granulation erfolgte von der Peripherie aus. Bereits nach 10 Tagen war die Wunde verschlossen und eine Narbenbildung war nicht ersichtlich.Granulation occurred from the periphery. After just 10 days, the wound was closed and no scarring was evident.
In einem späteren Versuch wurde ebenfalls ein Pferd behandelt, welches sich durch einen falschen Tritt ein erhebliches Hämatom an der linken hinteren Fessel zugezogen hatte. Auch hier wurde Propolis Salbe verwendet, mit dem Ergebnis, dass die Schwellung und die Durchblutung bereits nach 12 Stunden wieder normal war.In a later experiment, a horse was also treated which had suffered a significant hematoma on the left hind fetlock due to a wrong step. Here too, propolis ointment was used, with the result that the swelling and blood circulation were back to normal after just 12 hours.
Nächster Behandlungsfall war ein Pferd mit Einschuß des linken Hinterbeines. Erhebliche Schwellung, mit allen Kardinalzeichen einer Entzündung.The next case to be treated was a horse with a gunshot wound to the left hind leg. Considerable swelling, with all the cardinal signs of inflammation.
Hier wurde ebenfalls eine Propolis-Salbe Behandlung eingeleitet, mit dem Ergebnis der schnellen Abheilung und einer Restitutio ad integrum innerhalb von 4 Tagen.Here, too, a propolis ointment treatment was initiated, with the result of rapid healing and a restitutio ad integrum within 4 days.
Festzuhalten sei, dass es von dem Zeitpunkt der auslösenden Ursache einer Verletzung bishin zur Regeneration, die Abläufe bzw. die Teilaspekte einer Reaktion des Gewebes um einIt should be noted that from the time of the triggering cause of an injury to the regeneration, the processes or the partial aspects of a tissue reaction are a
vielfaches vermindert sind.are reduced many times over.
Es ist bekannt, dass 1954 durch GAPTRACHIMANOWA versuchsweise diese Salbe in der Anwendung bei Nekrobazillosen bei Schafen, Pferden und Rindern einen Heilerfolg von 84 %It is known that in 1954 GAPTRACHIMANOWA experimentally used this ointment to treat necrobacilli in sheep, horses and cattle, achieving a cure rate of 84%.
aufwiesen.had.
Ebenso wurden höchste therapeutische Effekte bei Verbrennungen erzielt. Hier wurde eine Heilung in nur 50% der sonst zu verwendeten Zeit erzielt.The highest therapeutic effects were also achieved in burns, with healing occurring in only 50% of the time normally required.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20306600U DE20306600U1 (en) | 2003-04-29 | 2003-04-29 | Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20306600U DE20306600U1 (en) | 2003-04-29 | 2003-04-29 | Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE20306600U1 true DE20306600U1 (en) | 2003-09-04 |
Family
ID=27816367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE20306600U Expired - Lifetime DE20306600U1 (en) | 2003-04-29 | 2003-04-29 | Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE20306600U1 (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2594336A1 (en) * | 1985-09-03 | 1987-08-21 | Brevier Christiane | Propolis: purified natural substance employed in agri-foodstuffs, agriculture, cosmetics, dermatology and hygiene products |
| JPS63179812A (en) * | 1987-01-22 | 1988-07-23 | Shiseido Co Ltd | External preparation for skin |
| DE69214732T2 (en) * | 1991-07-03 | 1997-05-15 | Lhd Lab Hygiene Dietetique | Healing wound dressing |
| JPH09208478A (en) * | 1996-02-06 | 1997-08-12 | Kazunori Murakami | Propolis preparation utilizing centrifugal separation method |
| DE19615293A1 (en) * | 1996-04-18 | 1997-10-23 | Johann Dibart | Propolis skin disorder salve |
| JPH10215815A (en) * | 1997-02-03 | 1998-08-18 | Shiyaburon:Kk | Propolis-containing cellulose |
| DE69228966T2 (en) * | 1991-08-27 | 1999-12-02 | Hayashibara Biochem Lab | Process for producing a purified propolis extract and its uses |
| DE19904801A1 (en) * | 1999-02-05 | 2000-08-10 | Klossner Axel | Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis |
| DE69802545T2 (en) * | 1997-08-11 | 2002-06-27 | Andre Pierre Morice | PROPOLIS AND AT LEAST ONE COMPOSITION CONTAINING ESSENTIAL OIL |
| DE69232338T2 (en) * | 1991-02-15 | 2002-09-19 | Fockerman, Jasmine | Benzopyranphenol derivatives for use as antibacterial, antiviral and wound healing agents |
| WO2002076411A2 (en) * | 2001-03-27 | 2002-10-03 | Dorian Owoc | Dermatological agent for the treatment of skin trauma, especially in burn conditions |
| JP2003055138A (en) * | 2001-08-08 | 2003-02-26 | Kenji Nakamura | Sheet cosmetic containing propolis |
-
2003
- 2003-04-29 DE DE20306600U patent/DE20306600U1/en not_active Expired - Lifetime
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2594336A1 (en) * | 1985-09-03 | 1987-08-21 | Brevier Christiane | Propolis: purified natural substance employed in agri-foodstuffs, agriculture, cosmetics, dermatology and hygiene products |
| JPS63179812A (en) * | 1987-01-22 | 1988-07-23 | Shiseido Co Ltd | External preparation for skin |
| DE69232338T2 (en) * | 1991-02-15 | 2002-09-19 | Fockerman, Jasmine | Benzopyranphenol derivatives for use as antibacterial, antiviral and wound healing agents |
| DE69214732T2 (en) * | 1991-07-03 | 1997-05-15 | Lhd Lab Hygiene Dietetique | Healing wound dressing |
| DE69228966T2 (en) * | 1991-08-27 | 1999-12-02 | Hayashibara Biochem Lab | Process for producing a purified propolis extract and its uses |
| JPH09208478A (en) * | 1996-02-06 | 1997-08-12 | Kazunori Murakami | Propolis preparation utilizing centrifugal separation method |
| DE19615293A1 (en) * | 1996-04-18 | 1997-10-23 | Johann Dibart | Propolis skin disorder salve |
| JPH10215815A (en) * | 1997-02-03 | 1998-08-18 | Shiyaburon:Kk | Propolis-containing cellulose |
| DE69802545T2 (en) * | 1997-08-11 | 2002-06-27 | Andre Pierre Morice | PROPOLIS AND AT LEAST ONE COMPOSITION CONTAINING ESSENTIAL OIL |
| DE19904801A1 (en) * | 1999-02-05 | 2000-08-10 | Klossner Axel | Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis |
| WO2002076411A2 (en) * | 2001-03-27 | 2002-10-03 | Dorian Owoc | Dermatological agent for the treatment of skin trauma, especially in burn conditions |
| JP2003055138A (en) * | 2001-08-08 | 2003-02-26 | Kenji Nakamura | Sheet cosmetic containing propolis |
Non-Patent Citations (3)
| Title |
|---|
| DAZ - Deutsche Apitherapie Zeitung, 3. Juli-Sept. 2001, S.6-11 * |
| http://gb.onlinehost.de/g/gb.pl?show&user=pferde&eintrag=20-29, Nr.68 Marion (Internet recherchiert am 28.07.2003) |
| http://gb.onlinehost.de/g/gb.pl?show&user=pferde&eNr.68 Marion (Internet recherchiert am 28.07.2003) * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69709682T2 (en) | GREEN OINTMENT | |
| DE68916430T2 (en) | PREPARATION OF MEDICINAL PRODUCTS FOR TREATING MASTITIS IN ANIMAL AND MAN. | |
| Kleinhenz et al. | Survey of veterinarians and hoof trimmers on methods applied to treat claw lesions in dairy cattle | |
| DE2414593A1 (en) | MEDICINAL PRODUCTS AND METHOD FOR ITS MANUFACTURING | |
| EP1095660A2 (en) | Therapeutic combination containing terpinen-4-ol and medicinal plants | |
| DE602005004030T2 (en) | COMPOSITION COMPRISING OIL AND HYPERICUM EXTRACT WITH LIGHTING, REJECTIVE AND BIOCIDAL PROPERTIES FOR THE TREATMENT OF OUTER WOUNDS | |
| DE20306600U1 (en) | Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier | |
| DE2307827A1 (en) | SUBSTANCE CONTAINING DIAETHYL PYROCARBONATE FOR VETERINAL MEDICAL OR COSMETIC USES | |
| DE10251753B4 (en) | Agent for the treatment of pain and inflammation in the horse, especially in joints | |
| EP2268294B1 (en) | Propolis extract | |
| RU2070409C1 (en) | Drug for treatment of mastitis in milking animals | |
| DE10143146B4 (en) | Anti-arthritic preparation and its use | |
| DE69730983T2 (en) | A NON-AQUEOUS ORAL ADMINISTRATIVE PASTE-FORM FOR MEDICAL DEVICE, METHOD FOR THE PRODUCTION THEREOF, AND THE USE OF AN OXYGEN-CARRIER FOR THE PRODUCTION OF SUCH A MEDIUM-SUBSTANCE | |
| EP2371350B1 (en) | Foam formulas for treating animal skin illnesses | |
| DE1745676B1 (en) | Process for the production of resorbable moldings for surgical purposes | |
| DE102025117620A1 (en) | Agents and their use in the treatment of digital dermatitis in equines | |
| León Cabanillas | Effects of Magnesium on the occurrence and expansion of spreading depolarization in gyrencephalic brains | |
| DE1492075A1 (en) | New cosmetic agent for hair loss and seborrhea, as well as process for the production of the same | |
| DE2047049A1 (en) | Calcium salt of N-acetylamino-6-hexanoic acid, its manufacture and use as a medicine | |
| WO1990010452A1 (en) | Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it | |
| DE2454164A1 (en) | Injections against magnesium tetany in ruminants - contg. a basic magnesium salt of acetylglutamic acid | |
| DE336051C (en) | Process for the production of medicinal and protective substances against tuberculosis | |
| DE541238C (en) | Process for the preparation of a serum preventing and curing tuberculosis | |
| DE1928428C (en) | Process for the production of a medicinal product with an inhibiting effect on the decrease in DNP-ATPase and the swelling of brain cells | |
| SU1750685A1 (en) | Preparation for treatment of necrobacteriosis hoof damages in cattle and a method of its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R086 | Non-binding declaration of licensing interest | ||
| R163 | Identified publications notified | ||
| R207 | Utility model specification |
Effective date: 20031009 |
|
| R156 | Lapse of ip right after 3 years |
Effective date: 20061101 |